EE04747B1 - Amiini-plaatina komplekside valmistamismeetod - Google Patents

Amiini-plaatina komplekside valmistamismeetod

Info

Publication number
EE04747B1
EE04747B1 EEP200100536A EEP200100536A EE04747B1 EE 04747 B1 EE04747 B1 EE 04747B1 EE P200100536 A EEP200100536 A EE P200100536A EE P200100536 A EEP200100536 A EE P200100536A EE 04747 B1 EE04747 B1 EE 04747B1
Authority
EE
Estonia
Prior art keywords
amine
preparation
platinum complexes
complexes
platinum
Prior art date
Application number
EEP200100536A
Other languages
English (en)
Estonian (et)
Inventor
S. Y. Wong Ernest
M. Giandomenico Christen
Original Assignee
Anormed Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc. filed Critical Anormed Inc.
Publication of EE200100536A publication Critical patent/EE200100536A/xx
Publication of EE04747B1 publication Critical patent/EE04747B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200100536A 1999-04-13 2000-04-11 Amiini-plaatina komplekside valmistamismeetod EE04747B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12893999P 1999-04-13 1999-04-13
PCT/CA2000/000385 WO2000061590A1 (en) 1999-04-13 2000-04-11 Process for preparing amine platinum complexes

Publications (2)

Publication Number Publication Date
EE200100536A EE200100536A (et) 2003-02-17
EE04747B1 true EE04747B1 (et) 2006-12-15

Family

ID=22437722

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100536A EE04747B1 (et) 1999-04-13 2000-04-11 Amiini-plaatina komplekside valmistamismeetod

Country Status (32)

Country Link
US (1) US6518428B1 (cs)
EP (1) EP1165576B1 (cs)
JP (1) JP4756669B2 (cs)
KR (1) KR100711955B1 (cs)
CN (3) CN1250559C (cs)
AR (1) AR043084A1 (cs)
AT (1) ATE309257T1 (cs)
AU (1) AU770006B2 (cs)
BG (1) BG65429B1 (cs)
BR (1) BR0009780B1 (cs)
CA (1) CA2368849C (cs)
CY (1) CY1104965T1 (cs)
CZ (1) CZ303156B6 (cs)
DE (1) DE60023859T2 (cs)
DK (1) DK1165576T3 (cs)
EE (1) EE04747B1 (cs)
ES (1) ES2253214T3 (cs)
HK (1) HK1039336B (cs)
HU (1) HUP0200748A3 (cs)
IL (1) IL145671A0 (cs)
IS (1) IS2709B (cs)
MX (1) MXPA01010430A (cs)
MY (1) MY122706A (cs)
NO (1) NO330429B1 (cs)
NZ (1) NZ514736A (cs)
PL (1) PL202731B1 (cs)
RU (1) RU2245340C2 (cs)
SK (1) SK286374B6 (cs)
TW (1) TWI289565B (cs)
UA (1) UA71614C2 (cs)
WO (1) WO2000061590A1 (cs)
ZA (1) ZA200107965B (cs)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
CZ303156B6 (cs) 1999-04-13 2012-05-09 Anormed Inc. Komplex cisplatiny a zpusob jeho prípravy
US6413953B1 (en) * 1999-04-13 2002-07-02 Anormed Inc. Pt(IV) antitumor agent
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
US6806289B1 (en) * 2000-07-14 2004-10-19 Stephen J. Lippard Coordination complexes, and methods for preparing by combinatorial methods, assaying and using the same
US6894049B1 (en) 2000-10-04 2005-05-17 Anormed, Inc. Platinum complexes as antitumor agents
EP1967189A1 (en) 2004-02-18 2008-09-10 GPC Biotech AG Methods for treating resistant or refractory tumors
CZ296459B6 (cs) * 2004-09-14 2006-03-15 Pliva-Lachema A. S. Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
ES2257178B1 (es) * 2004-09-30 2007-08-16 Universidad Autonoma De Madrid Compuestos de platino de formula trans-(ptc12(isopropilamina)(4-(hidroximetil)-piridina)) y trans-(ptc12(isopropilamina)(3-hidroximetil)-piridina y su aplicacion como farmaco antitumoral.
RU2298556C1 (ru) * 2005-11-17 2007-05-10 Общество с ограниченной ответственностью "ЦитоСтарт" Триметилоламинометановая соль цис-бис [4-нитраминопиридин-n] тетрахлороплатины (iv) и способ ее получения
RU2309158C1 (ru) * 2006-03-27 2007-10-27 Институт химии и химической технологии СО РАН (ИХХТ СО РАН) Способ получения цис-дихлороамминизопропиламинплатины (ii)
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) * 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
CN101809024A (zh) * 2007-07-16 2010-08-18 铂雅制药公司 吡铂的口服制剂
WO2009099649A1 (en) * 2008-02-08 2009-08-13 Poniard Pharmaceuticals, Inc. Use of picoplatin and bevacizumab to treat colorectal cancer
JP2012530068A (ja) * 2009-06-12 2012-11-29 ポニアード ファーマシューティカルズ， インコーポレイテッド ピコプラチンの改良された合成
RU2451010C1 (ru) * 2011-01-11 2012-05-20 Закрытое Акционерное Общество "Ива Фарм" Палладиево-медные катализаторы гомогенного селективного окисления тиольных групп, комбинация и композиция на их основе и способ терапевтического воздействия
CN103554188B (zh) * 2013-11-19 2016-03-02 辽宁大学 6-(氮杂环取代)蒽醌二氯化铂配合物及其制备方法和应用
CN103860539B (zh) * 2014-04-14 2016-02-10 于迎涛 一种具有混合轴向配体的Pt（IV）类抗癌药物及制备方法
CN104231000A (zh) * 2014-08-20 2014-12-24 山东铂源药业有限公司 一种抗肿瘤药物甲啶铂的合成方法
WO2017192290A1 (en) 2016-05-04 2017-11-09 The Wistar Institute Of Anatomy And Biology Methods of treating cancers overexpressing carm1 with ezh2 inhibitors and platinum-based antineoplastic drugs
KR102137669B1 (ko) * 2019-08-05 2020-07-27 한국과학기술연구원 메탄올 또는 그 전구체 합성용 촉매, 이의 제조방법 및 이를 이용한 메탄올 또는 그 전구체의 제조방법
WO2022008149A1 (en) 2020-07-08 2022-01-13 Dayton Therapeutics Ag Satraplatin for use in the treatment of lymphoid neoplasms
CN113402565B (zh) * 2021-06-16 2023-07-28 中国人民解放军空军军医大学 一类含有泊沙康唑的四价铂配合物、制备方法及其应用
CN118829730A (zh) 2022-01-07 2024-10-22 瑞士制药有限公司 用沙铂治疗血液学恶性肿瘤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA805101B (en) 1979-08-23 1981-08-26 Johnson Matthey Co Ltd Compositions containing platinium
US4533502A (en) * 1983-02-22 1985-08-06 Rochon Fernande D Platinum (II) compounds and their preparation
DE3582961D1 (de) * 1984-06-27 1991-07-04 Johnson Matthey Plc Platinkoordinationsverbindungen.
US5244919A (en) 1988-02-02 1993-09-14 Johnson Matthey, Inc. Pt(IV) complexes as anti-tumor agents
SU1790190A1 (ru) * 1990-08-08 1996-04-27 Ленинградский химико-фармацевтический институт Цис-хлордиаммин-1,3-диметилксантинплатины (ii) хлорид дигидрат, проявляющий противоопухолевую активность
GB9105037D0 (en) 1991-03-09 1991-04-24 Johnson Matthey Plc Improvements in chemical compounds
RU2050361C1 (ru) * 1991-12-23 1995-12-20 Юрий Михайлович Островский Пентахлороплатинат (iv)-4- метил-3-[(2- метил-4- окси-5-пиримидинил) метил-]-5-(2 -оксиэтил)тиазолия, проявляющий противоопухолевую активность
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
US5547982A (en) * 1995-02-27 1996-08-20 Johnson Matthey, Inc. Anti-tumor platinum complexes
RU2089555C1 (ru) * 1995-05-04 1997-09-10 Новосибирский институт биоорганической химии СО РАН Бисимидазол-(1,10)-фенантролинплатина (iii) дихлорид, проявляющий цитостатическую противоопухолевую активность
WO2000056743A1 (en) 1999-03-19 2000-09-28 Anormed Inc. Pharmaceutical compositions comprising metal complexes
CZ303156B6 (cs) 1999-04-13 2012-05-09 Anormed Inc. Komplex cisplatiny a zpusob jeho prípravy

Also Published As

Publication number Publication date
DK1165576T3 (da) 2006-03-27
JP2002541263A (ja) 2002-12-03
RU2245340C2 (ru) 2005-01-27
IL145671A0 (en) 2002-06-30
SK286374B6 (sk) 2008-08-05
HK1039336B (en) 2006-01-27
IS2711B3 (is) 2011-01-15
BR0009780B1 (pt) 2013-09-24
ES2253214T3 (es) 2006-06-01
ATE309257T1 (de) 2005-11-15
CN1916009A (zh) 2007-02-21
KR100711955B1 (ko) 2007-05-02
BG106090A (en) 2002-06-28
CA2368849A1 (en) 2000-10-19
BR0009780A (pt) 2002-01-02
DE60023859D1 (de) 2005-12-15
HK1100562A1 (en) 2007-09-21
IS2709B (is) 2011-01-15
WO2000061590A1 (en) 2000-10-19
JP4756669B2 (ja) 2011-08-24
CZ303156B6 (cs) 2012-05-09
PL202731B1 (pl) 2009-07-31
SK14682001A3 (sk) 2002-01-07
TWI289565B (en) 2007-11-11
NO330429B1 (no) 2011-04-11
CZ20013648A3 (cs) 2002-02-13
EP1165576A1 (en) 2002-01-02
CN1250559C (zh) 2006-04-12
CN1916009B (zh) 2010-12-15
MY122706A (en) 2006-04-29
PL351612A1 (en) 2003-05-05
KR20020018189A (ko) 2002-03-07
NZ514736A (en) 2004-01-30
AU3951000A (en) 2000-11-14
IS6092A (is) 2001-09-28
DE60023859T2 (de) 2006-08-03
ZA200107965B (en) 2003-01-02
CN1350540A (zh) 2002-05-22
EE200100536A (et) 2003-02-17
CN1847253A (zh) 2006-10-18
EP1165576B1 (en) 2005-11-09
HUP0200748A3 (en) 2010-01-28
MXPA01010430A (es) 2002-03-27
HUP0200748A2 (hu) 2002-07-29
US6518428B1 (en) 2003-02-11
AU770006B2 (en) 2004-02-12
CY1104965T1 (el) 2010-03-03
NO20014957L (no) 2001-12-03
AR043084A1 (es) 2005-07-20
HK1039336A1 (en) 2002-04-19
BG65429B1 (bg) 2008-07-31
CN100460412C (zh) 2009-02-11
UA71614C2 (en) 2004-12-15
CA2368849C (en) 2011-01-25
NO20014957D0 (no) 2001-10-12

Similar Documents

Publication Publication Date Title
EE200100536A (et) Amiini-plaatina komplekside valmistamismeetod
IS5982A (is) Aðferð til framleiðslu á 5-sýanóþalíði
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20002319D0 (no) FremgangsmÕte for fremstilling av fulven-metallkomplekser
NO983068D0 (no) FremgangsmÕte for fremstilling av bis-syklopentadienyl-dien komplekser
NO995851L (no) Fremstillingsfremgangsmåte for isoksasolidinedion forbindelse
NO20030515D0 (no) Fremgangsmåte for fremstilling av dinapsolin
NO20003454D0 (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
GB2363605B (en) Process for the preparation of alpha-aminoketone derivatives
NO20013995L (no) Fremgangsmåte for fremstilling av L-sorbose
HUP0202865A3 (en) Process for the preparation of 2-cyanopyridines
IL138691A (en) Process for the preparation of 3-acyl-indoles
NO20022956D0 (no) Fremgangsmåte for fremstilling av nitroguanidin
NO20011652L (no) Fremgangsmåte for fremstilling av 1,5-diaryl-3-substituerte pyrazoler
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20023702L (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20012811D0 (no) Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO20021788D0 (no) Fremgangsmåte for fremstilling av ulcerterapeutika
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
NO20013044D0 (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
EE200200053A (et) Isoretinoiini valmistamise protsess
NO20002558D0 (no) FremgangsmÕte for fremstilling av findisperse eksplosivstoffer
NO990870D0 (no) FremgangsmÕte for fremstilling av syntetisk wollastonitt
PL352099A1 (en) Process for the preparation of tetrafluorohalogenbenzenes
NO20016281D0 (no) Fremgangsmåte for fremstilling av legemiddel- mellomproduktforbindelser

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20140411